Abstract:Parkin is an E3 ubiquitin ligase involved in Parkinson's disease (PD). Necroptosis is a regulated form of cell death that depends on receptor interacting protein 1 (RIP1) and 3 (RIP3). Importantly, parkin has been implicated in ubiquitination events that can alter inflammation and necroptosis. Here, we investigated how parkin influences microglial function. Incubation of BV-2 microglial cells with zVAD.fmk (zVAD) induced high levels of cell death and viability loss, while N9 microglial cells and primary microglia required further stimuli. Importantly, necrostatin-1 (Nec-1), an inhibitor of RIP1 kinase activity, abrogated cell death, thus implicating RIP1-dependent necroptosis in cell death. Cell death was characterized by necrosome assembly, as determined by sequestration of RIP1/RIP3 in insoluble fractions and by MLKL phosphorylation, which were all abolished by Nec-1. Also, necroptosis-inducing conditions led to TNF-α secretion, which may in turn contribute to autocrine necroptosis activation. Interestingly, parkin knockdown protected BV-2 cells from zVAD-induced necroptosis, which may depend on the higher RIP1 ubiquitination levels detected in siRNA-PARK2 transfected cells. This effect was independent of inflammation, since pro-inflammatory stimulation of BV-2 and primary microglia with silenced parkin resulted in stronger pro-inflammatory gene expression, an opposite observation from zVAD-exposed BV-2 cells. LPS-mediated inflammation was exacerbated by NF-κB/JNK over-activation. Finally, no alterations in mitochondrial ROS production were detected in any condition, thereby excluding the role of parkin in mitophagy. In conclusion, here, we reveal that parkin may have unsuspected roles in microglia by modulating ubiquitination. Parkin loss exacerbates inflammation and promotes survival of activated microglia, thus contributing to chronic neuroinflammation.

Parkin regulates NF-κB by mediating site-specific ubiquitination of RIPK1

Activation of Ikk by Tnf Alpha Requires Site-Specific Ubiquitination of Rip1 and Polyubiquitin Binding by Nemo

Parkin regulates microglial NLRP3 and represses neurodegeneration in Parkinson's disease

Ubiquitination of RIP is Required for Tumor Necrosis Factor Α-Induced NF-κB Activation

Regulation of Innate Immune Responses by Receptor Interacting Protein Kinases (172.43)

Linear Ubiquitination of RIPK1 on Lys612 Regulates Systemic Inflammation via Preventing Cell Death.

Loss of Microglial Parkin Inhibits Necroptosis and Contributes to Neuroinflammation

Parkin Modulates Err Alpha/Enos Signaling Pathway In Endothelial Cells

K63-linked Ubiquitination Regulates RIPK1 Kinase Activity to Prevent Cell Death During Embryogenesis and Inflammation

Regulation of a distinct activated RIPK1 intermediate bridging complex I and complex II in TNFα-mediated apoptosis

Inhibition of BAK Apoptotic Activity by Parkin-mediated Ubiquitination

Palmitoylation licenses RIPK1 kinase activity and cytotoxicity in the TNF pathway

Death-domain dimerization-mediated activation of RIPK1 controls necroptosis and RIPK1-dependent apoptosis

Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling.

TAK1 is Recruited to the Tumor Necrosis Factor-α (Tnf-Α) Receptor 1 Complex in a Receptor-interacting Protein (Rip)-Dependent Manner and Cooperates with MEKK3 Leading to NF-κB Activation*

Genomic locus proteomic screening identifies the NF-κB signaling pathway components NFκB1 and IKBKG as transcriptional regulators of Ripk3 in endothelial cells

Parkin activates innate immunity and promotes anti-tumor immune responses

Tyrosine Phosphorylation Regulates RIPK1 Activity to Limit Cell Death and Inflammation.

Regulatory mechanisms of RIPK1 in cell death and inflammation

RIPK1 Dephosphorylation and Kinase Activation by PPP1R3G/PP1γ Promote Apoptosis and Necroptosis.

Parkin Mono-Ubiquitinates Bcl-2 And Regulates Autophagy